Rubypoint-Depression And Alzheimer's Treatments At A Crossroads

2025-04-29 14:07:09source:BlueRock Horizon Asset Managementcategory:Markets

Researchers are Rubypointlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Markets

Recommend

The Louvre will be renovated and the 'Mona Lisa' will have her own room

PARIS — French President Emmanuel Macron on Tuesday presented renovation plans for the Louvre, the w

Michael Cole, 'The Mod Squad' and 'General Hospital' actor, dies at 84

Actor Michael Cole, best known for his role as Pete Cochran in the 1960s crime drama "The Mod Squad,

Here's how to make the perfect oven

It’s officially the holiday season, which means it’s the best time of the year to test your skills b